Premium
A case of erythema multiforme drug eruption associated with erythrodermic psoriasis induced by sofosbuvir and daclatasvir
Author(s) -
Wang Y.,
Liu P.
Publication year - 2017
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.12467
Subject(s) - dermatology , sofosbuvir , drug eruption , medicine , psoriasis , erythema multiforme , drug , pharmacology , virology , hepatitis c virus , virus , ribavirin
Summary What is known and the objective Sofosbuvir ( SOF ) and daclatasvir ( DCV ) have revolutionized the treatment of hepatitis C virus and now represent the preferred therapy for this disease. Limited data are available on the dermatological side effects resulting from co‐administration of SOF and DCV . Case description We report a case of an erythema multiforme drug eruption associated with erythrodermic psoriasis induced by SOF and DCV . After ceasing treatment, the skin condition significantly improved. What is new and conclusion We should pay attention to adverse skin reactions resulting from SOF and DCV , especially if the patient has a pre‐existing dermatosis.